JPRN-UMIN000048389已完成Unknown
Effects of Kampo medicines on the prevention of COVID-19 - Prevention of COVID-19 with Kampo medicines
Department of Internal Medicine, Sapporo Suzuki Hospital0 个研究点目标入组 38 人开始时间: 2023年12月24日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 38
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Someone which has a history of side effects to Kampo medicines
研究者
相似试验
招募中
不适用
The effect of Kampo medicine for prevention of chronic subdural hematoma recurrence-prosepective studychronic subdural hematomaJPRN-UMIN000027747Cerebrovascular Research Institute, Eishokai Yoshida Hospital300
已完成
2 期
Preventive effect of Kampo medicine (Hangeshashin-to) plus Minocycline against afatinib-induced diarrhea, mucositis oral and rash acneiform in patients with non-small cell lung cancer:Multicenter Phase II studyEGFR mutation-positive non-small cell lung cancerJPRN-UMIN000018392ational Hospital Organization Kyushu Medical Center Department of Respiratory Medicine28
招募中
3 期
Effect of plantago ovata forsk on prevention of constipation among patients with acute myocardial infarctioIRCT20180712040439N1Arak University of Medical Sciences110
撤回
不适用
The use of CoCo in a conservative treatment of patients with hip and knee osteoarthritis.osteoarthritisNL-OMON37638Revalidatiecentrum Het Roessingh40
招募中
3 期
Cyclosporin for the Prevention and Treatment of COVID-19 DiseaseIRCT20150107020592N22Shahid Beheshti University of Medical Sciences60